… risk factor for impaired cardiovascular health, with cardiovascular disease being the leading
… prevalence of cardiovascular disease including heart failure, coronary artery disease, and …

… In this article, we discuss the biology of EPCs, their therapeutic potential in the treatment
of cardiovascular diseases, and the limitations facing their use in the clinic. We end with a …

… This article reviews the potential and methods of MSC transplantation in the treatment of
cardiovascular diseases (CVDs) and the challenges of the clinical use of MSCs. …

Adipose-derived stem cells (ADSCs) are easily obtained and expanded, and have emerged
as a novel source of adult stem cells for the treatment of cardiovascular diseases. These …

… These studies underline the therapeutic potential of NPs in the treatment of acute MI, and …
However, studies exploring this therapeutic potential of ANP have not been reported to date…

… Cardiovascular disease (CVD) represents the leading cause of death worldwide. Citation1
Lipid-lowering therapy is one of the mainstay therapies for cardiovascular risk reduction. …

… , 2) summarize the advances on the detrimental and beneficial role of exosomes in cardiac
remodeling, and 3) discuss the therapeutic potential of exosomes in cardiovascular diseases. …

… 1 antagonists were found to reverse the decreased cardiac contractility, suggesting their
therapeutic potential. Obesity is often associated with decreased cardiac contractility, 60,61 the …

… , peripheral vascular disease and heart failure. The present article is intended to emphasize
the therapeutic potentials of PTXF in different types of cardiovascular diseases, focusing on …

… clinical development for various cardiovascular indications. Because PARP … , their therapeutic
potential is also being explored for cancer treatment. This review discusses the therapeutic …